HIGHLIGHTS
- who: HLA matched sibling or and colleagues from the (UNIVERSITY) have published the research work: Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in donor transplant for patients with acute leukemia on behalf of ALWP-EBMT, in the Journal: (JOURNAL)
- what: The study aim was to evaluate PT-Cy as GVHD prophylaxis post-HSCT from MSD and UD transplants. This study was approved by the ALWP of the EBMT institutional review board and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All patients or legal guardians provided written informed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.